Viallmed CPI
What do physicians actually choose?
Specialists' decisions on clinical cases become a ranking of therapies and its dynamics over time.
- 01Compound A20.1%
- 02Compound B19.4%
- 03Compound C18.1%
- 04Compound D16.8%
- 05Compound E14.2%
One operating layer for pharma's HCP channels: what physicians decide, what your websites risk, and next, what you say everywhere else.
Public HCP surfaces and physicians' decisions on clinical cases.
Risk checks across six areas. Preference rankings across therapies.
Evidence, a risk level and the change to make. Rankings with their dynamics.
Change over time, so new risks and shifts are visible when they happen.
What do physicians actually choose?
Specialists' decisions on clinical cases become a ranking of therapies and its dynamics over time.
What do our HCP websites risk?
A risk review of pharma websites for physicians, with screenshots, a risk level and what to fix.
What are we saying everywhere else?
Monitoring of ads, email and social channels. Pre-MLR checks of materials before they go to review.
Every finding links to a screenshot or a source. Nothing rests on an opinion alone.
Public surface only. No forms submitted, no access controls bypassed.
Digital, brand, medical and compliance see the same picture and the same next step.